About Us
Premium Insights
Expert Views
Compliance
Experts
Careers
Contact Us
Our Expert Views content provides the ideal narrative for businesses, subject matter experts, and those interested in the expert network industry's latest trends and talking points. These in-depth perspectives cover various industries, business verticals, sectors, and regions, supporting our global clientele.
NA
The article explores digital transformation, sustainability, and outsourcing trends in India’s pharmaceutical manufacturing sector, highlighting innovation, regulatory shifts, and strategic priorities for industry growth and investment.
Senior Lead of Physical Therapy (Jul 2025 – Present)
The GCC’s sports medicine market is growing fast, fuelled by national sports strategies, international talent influx, and an evolving healthcare infrastructure leveraging AI, regenerative medicine, and tech-enabled rehab solutions.
Director, IT Business Operations (Sep 2022 – Present)
The article explores digital transformation in life sciences and healthcare, covering IT integration, regulatory trends, new business models, digital disruption, and critical investor questions in a rapidly evolving industry.
Director - Patient Access (Aug 2021-Present)
The article examines revenue cycle transformation in healthcare, automation ROI, leading platforms, payer reimbursement policies, cybersecurity shifts, and critical investor questions shaping industry innovation.
Managing Director & Country Head, D2Sol India: Corporate VP (Jan 2025 – Present)
The article explores the evolution of healthcare GCCs in India, highlighting innovation, AI-driven growth, emerging tech adoption, talent strategies, cybersecurity, and investment opportunities in a rapidly maturing sector.
Experienced Biopharmaceutical Professional | Former Head of Section - Biologics Cell Line, Viral Vector, mRNA Therapeutics Development (Jan 2021 - Dec 2022)
The article analyzes biopharma’s cell line development, AI-driven innovation, CGT manufacturing shifts, mRNA regulatory challenges, and key investor questions shaping the future of personalized medicine and advanced therapeutics.